Cas:96553-02-5 methyl(gypsogenin-3-O-β-D-glucopyranoside)uronate manufacturer & supplier

We serve Chemical Name:methyl(gypsogenin-3-O-β-D-glucopyranoside)uronate CAS:96553-02-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

methyl(gypsogenin-3-O-β-D-glucopyranoside)uronate

Chemical Name:methyl(gypsogenin-3-O-β-D-glucopyranoside)uronate
CAS.NO:96553-02-5
Synonyms:Olean-12-en-28-oic acid, 3-[[(2ξ)-6-methyl-D-arabino-hexopyranuronosyl]oxy]-23-oxo-;gypsogenin-3-O-glucuronide;28-Hydroxy-23,28-dioxoolean-12-en-3-yl methyl (2ξ)-D-arabino-hexopyranosiduronate;methyl(gypsogenin-3-O-Beta-D-glucopyranoside)uronate;methyl(gypsogenin-3-O–D-glucopyranoside)uronate;Gypsogenin 3-O-Beta-D-glucuronopyranoside;methyl(gypsogenin-3-O-β-D-glucopyranoside)uronate
Molecular Formula:C37H56O10
Molecular Weight:660.834
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:743.1±60.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.582
PSA:159.82000
Exact Mass:660.387329
LogP:8.95

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Olean-12-en-28-oic acid, 3-[[(2ξ)-6-methyl-D-arabino-hexopyranuronosyl]oxy]-23-oxo- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,methyl(gypsogenin-3-O-β-D-glucopyranoside)uronate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,gypsogenin-3-O-glucuronide Use and application,methyl(gypsogenin-3-O–D-glucopyranoside)uronate technical grade,usp/ep/jp grade.


Related News: API (Active Pharmaceutical Ingredient) means the active ingredient which is contained in medicine. methyl(gypsogenin-3-O-β-D-glucopyranoside)uronate manufacturer In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of ��predictable�� clinical value for life-threatening diseases for which effective treatment is not immediately available. methyl(gypsogenin-3-O-β-D-glucopyranoside)uronate supplier Today, Novavax is one step closer to addressing the critical and persistent global public health need for additional COVID-19 vaccines,” Novavax president and CEO Stanley Erck said in a statement. “These clinical results reinforce that [the vaccine] is extremely effective and offers complete protection against both moderate and severe COVID-19 infection. methyl(gypsogenin-3-O-β-D-glucopyranoside)uronate vendor API (Active Pharmaceutical Ingredient) means the active ingredient which is contained in medicine. methyl(gypsogenin-3-O-β-D-glucopyranoside)uronate factory In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of ��predictable�� clinical value for life-threatening diseases for which effective treatment is not immediately available.